PharmaKD Overview

  • Founded
  • 2004
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

PharmaKD General Information


Designer and developer of PK/PD technologies to support pharmaceutical and biotechnology industries. The company provides proprietary mass spectrometry-based platforms for automated drug metabolite profiling (DMDiscovery) and biomarker discovery (MarkerScan), as well as high throughput drug-protein binding (HT PB) assays. Its technologies are used for predicting drug efficacy, drug toxicity, and monitoring disease progression.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Devices and Supplies
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • 35 Cabot Road
  • Woburn, MA 01801
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaKD Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaKD‘s full profile, request access.

Request a free trial

PharmaKD Executive Team (1)

Name Title Board Seat Contact Info
Lily Li Ph.D President
To view PharmaKD’s complete executive team members history, request access »